Zynerba Pharmaceuticals (ZYNE)

[Leonard McKinley]

I have not read the actual filings. I am only skimming the press releases as I think it is all rubbish. However, I think that they are generally alleging that management did not fairly represent the risk of failure of the trials and bad FDA results. Most of these suits will not even get to negotiation as the class will not achieve certification, I think.
I expect that a rational judge will see that the market reaction to the last trial result report was absurd and that the market reaction was just plain wrong. Management cannot be held responsible for irrational market behavior.
I am not worried about them. This is an honest management team with a terrific product and market opportunity. Zynerba is going to destroy GWPH because once Zynerba has any full FDA approval (which is a certainty in my opinion), most doctors will prescribe Zynerba's product for the indications for which GWPH has FDA approval. This will happen because the doctors will know that it is the same molecule but with a superior delivery system that has lower and less risky side effects (i.e. liver risk). The doctors will have virtually zero malpractice risk because IT IS THE SAME MOLECULE! The only risk factor will be that the Zynerba delivery system may require a lower dosage than the GWPH system because Zynerba's trans-dermal delivery is more efficient than the oral system of GWPH.